TY - JOUR
T1 - Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.
AU - Lorenc, Z. Paul
AU - Kenkel, Jeffrey M.
AU - Fagien, Steven
AU - Hirmand, Haideh
AU - Nestor, Mark S.
AU - Sclafani, Anthony P.
AU - Sykes, Jonathan M.
AU - Waldorf, Heidi A.
PY - 2013/3
Y1 - 2013/3
N2 - In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.
AB - In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.
UR - http://www.scopus.com/inward/record.url?scp=84883046783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883046783&partnerID=8YFLogxK
U2 - 10.1177/1090820X13480479
DO - 10.1177/1090820X13480479
M3 - Article
C2 - 23515197
AN - SCOPUS:84883046783
VL - 33
SP - 35S-40S
JO - Seminars in Fetal and Neonatal Medicine
JF - Seminars in Fetal and Neonatal Medicine
SN - 1744-165X
IS - 1 Suppl
ER -